LFVN Lifevantage

LifeVantage to Participate in the Sidoti Micro Cap Conference

LifeVantage to Participate in the Sidoti Micro Cap Conference

SALT LAKE CITY, May 06, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the Sidoti Micro Cap Conference, to be held May 8-9, 2024.

Mr. Fife and Mr. Aure will meet with investors and present at approximately 1:00 p.m. Eastern Time on Wednesday, May 8, 2024. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at  or directly . A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company’s website.

About LifeVantage Corporation

(Nasdaq: LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and probiotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+, ProBio, IC Bright®, Daily Wellness, Rise AM, Reset PM, and D3+ dietary supplements, the TrueScience® line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit . 

Investor Relations Contact: 

Reed Anderson, ICR 

(646) 277-1260 



EN
06/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

Doug Lane
  • Doug Lane

3QFY24 Profit Upside on Modest Sales Shortfall; Raising FY24 EBITDA bu...

3QFY24 EPS was $0.21 versus a depressed $0.08 in 3QFY23 and above our $0.16 estimate. 3QFY24 EBITDA of $5.1 million beat our $4.6 million estimate and was up sharply from $3.3 million a year ago. EBITDA margin of 10.5% exceeded our 8.7% estimate, driven primarily by lower commissions and incentives as a percentage of sales than we expected (210 bps), as well as lower SG&A (70 bps). This was partially offset by gross margin of 78.9%, which was below our 80.0% estimate and 80.2% in the year-ago ...

 PRESS RELEASE

LifeVantage to Participate in the Sidoti Micro Cap Conference

LifeVantage to Participate in the Sidoti Micro Cap Conference SALT LAKE CITY, May 06, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the Sidoti Micro Cap Conference, to be held May 8-9, 2024. Mr. Fife and Mr. Aure will meet with investors and present at approximately 1:00 p.m. Eastern Time on Wednesday, May 8, 2024. A li...

 PRESS RELEASE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid June 14, 2024 to all stockholders of record at the close of business on May 31, 2024. This represents an increase in the dividend amount by 14.3% over the previous quarter. About LifeVantage Corpor...

 PRESS RELEASE

LifeVantage Announces Financial Results for the Third Quarter of Fisca...

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2024 SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2024. Third Quarter Fiscal 2024 Summary*: Revenue of $48.2 million, a decrease of 10.2% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue was down approximately 8.7...

 PRESS RELEASE

LifeVantage to Announce Third Quarter Fiscal Year 2024 Results on May ...

LifeVantage to Announce Third Quarter Fiscal Year 2024 Results on May 2, 2024 SALT LAKE CITY, April 18, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2024, after the stock market closes on Thursday, May 2, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in parti...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch